- Home
- KWR vs RXRX Comparison
KWR vs RXRX Comparison
Compare KWR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KWR
- RXRX
- Stock Information
- Founded
- KWR 1918
- RXRX 2013
- Country
- KWR United States
- RXRX United States
- Employees
- KWR N/A
- RXRX N/A
- Industry
- KWR Major Chemicals
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- KWR Industrials
- RXRX Health Care
- Exchange
- KWR Nasdaq
- RXRX Nasdaq
- Market Cap
- KWR 2.2B
- RXRX 2.0B
- IPO Year
- KWR 1985
- RXRX 2021
- Fundamental
- Price
- KWR $114.66
- RXRX $5.81
- Analyst Decision
- KWR Strong Buy
- RXRX Buy
- Analyst Count
- KWR 5
- RXRX 5
- Target Price
- KWR $155.40
- RXRX $7.00
- AVG Volume (30 Days)
- KWR 187.1K
- RXRX 31.9M
- Earning Date
- KWR 07-31-2025
- RXRX 08-11-2025
- Dividend Yield
- KWR 1.69%
- RXRX N/A
- EPS Growth
- KWR N/A
- RXRX N/A
- EPS
- KWR 5.29
- RXRX N/A
- Revenue
- KWR $1,812,841,000.00
- RXRX $59,790,000.00
- Revenue This Year
- KWR $1.16
- RXRX $19.96
- Revenue Next Year
- KWR $5.16
- RXRX $61.39
- P/E Ratio
- KWR $21.67
- RXRX N/A
- Revenue Growth
- KWR N/A
- RXRX 29.32
- 52 Week Low
- KWR $95.91
- RXRX $3.79
- 52 Week High
- KWR $184.79
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- KWR 43.14
- RXRX 52.21
- Support Level
- KWR $117.38
- RXRX $5.93
- Resistance Level
- KWR $125.72
- RXRX $6.69
- Average True Range (ATR)
- KWR 4.38
- RXRX 0.50
- MACD
- KWR -1.12
- RXRX -0.00
- Stochastic Oscillator
- KWR 4.40
- RXRX 33.66
About KWR Quaker Houghton
Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.